Hafrun Fridriksdottir, Executive VP, Global R&D at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 514 shares at $7.16 ($4K) on 2020-03-17, disclosed to the SEC on 2020-03-19.
Scheduled sale ($4k) by Executive VP, Global R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.16 | 134 | $959 | 26.1% |
| 2 | $7.16 | 380 | $3K | 73.9% |
| Total | $7.16 avg | 514 | $4K | 100% |
| Filing → |
| TEVA | SELL | 2022-03-02 | $124K | — | Filing → |
| TEVA | SELL | 2022-02-10 | $111K | — | Filing → |
| TEVA | SELL | 2021-08-12 | $1.0M | — | Filing → |